Highly Specialized in preclinical studies
Preclinical
CRO Services
Gubra offers expert preclinical research services enabling pharmaceutical and biotech companies to advance their drug development pipeline. Our capabilities in preclinical studies include in vivo pharmacology, ex vivo assays, drug profiling, histology, stereology and whole brain and organ imaging. We employ a combination of unique techniques to profile drug candidates in a wide array of clinically translatable research models.
Preclinical Contract Research Services
By disease areas
Liver (NASH/MASH)
Test your compound in our validated NASH/MASH mouse models.
Obesity
Progress your study with our readily available DIO models.
Kidney (DKD/CKD/PKD/AKI)
Explore our broad and advanced preclinical kidney model portfolio.
CNS
Visualize and quantify your drug’s effects on the brain to progress your study with more certainty.
Lung (IPF)
Benefit from our extensive knowhow in IPF and highly advanced models.
Heart (CVD)
Test the efficacy of your novel agents in our models tailored for your needs.
Intestine (IBD)
Explore histopathological endpoints in our chronic DSS-IBD mouse model.
Diabetes
Qualify and advance your assessment of novel compounds.
Non-rodent Studies
Use Gubra’s state-of-the-art PK, NGS and bioinformatics platform in miniature pigs.
By technology
3D Imaging
Visualize and quantify your drug candidate’s effects in any organs.
2D Histology
Benefit from our expert 2D histology technologies.
RNAseq
Unlock the molecular mode of action of your compounds with our advanced services.
Choose the right
Preclinical CRO Service
Provider
We are highly specialized and experienced in bridging preclinical and clinical drug development. We provide clear and conclusive data with precise, detailed data presentation. Partner with us and get expert advice on your preclinical studies.
For further information
Contact us
Gubra
Hørsholm Kongevej 11B
2970 Hørsholm
Denmark
+45 3152 2650